FindTrial
Sign In

SETRAPED : A prospective, multicenter study evaluating the efficacy and tolerance of transmucosal midazolam for proportionate palliative sedation in children with refractory symptoms

Status
Not yet recruiting
Phases
Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-523840-11-00
Enrollment
50
Registered
2026-07-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children with refractory symptoms

Brief summary

To describe the efficacy of proportional sedation using transmucosal midazolam in pediatric palliative patients presenting with refractory symptoms

Interventions

DRUGMIDAZOLAM

Sponsors

Centre Leon Berard
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
0 Years to 17 Years

Design outcomes

Primary

MeasureTime frame
To describe the efficacy of proportional sedation using transmucosal midazolam in pediatric palliative patients presenting with refractory symptoms—

Outcome results

None listed

Source: EU CTIS · Data processed: Jul 18, 2026